Skip to Content

'
Camilo Jimenez, M.D.

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Co-Chair, International Society for Pheochromocytoma and Paraganglioma Research Support PRESSOR, Houston, TX

Dual/Joint/Adjunct Appointment

Adjunct Professor, The William J. Harrington Medical Training Program of Latin America, The University of Miami, Jackson Memorial Hospital, Miami, FL

Bio Statement

Dr. Jimenez is an Associate Professor of Endocrine Neoplasia and Hormonal Disorders. He has performed extensive clinical research in the field of endocrine cancer with a particular interest in pheochromocytomas and paragangliomas. Dr. Jimenez was one of the first clinicians to describe the use tyrosine kinase inhibitors in patients affected with sporadic and hereditary (Von Hippel-Lindau and Paraganglioma syndrome type 4) malignant pheochromocytomas and sympathetic paragangliomas. His observations led to the development of prospective multi-institutional, international clinical trials. Dr. Jimenez also characterized inherent complications related to excessive hormonal secretion and tumor burden distinctive of this disease. His seminal accomplishments include assessing the value of antiresortive agents and chemotherapy against bone metastases; demonstrating that systemic chemotherapy with cyclophosphamide, vincristine, and dacarbazine is associated with an improved overall survival; and describing the clinical predictors of aggressiveness and overall survival of these tumors. Dr. Jimenez has published more than 60 manuscripts in high impact journals and chapters for prestigious books, including Harrison’s Principles of Internal Medicine and Thyroid. He is member of the editorial board for the Journal of Clinical Endocrinology and Metabolism, and he is the principal investigator and collaborator for several clinical and laboratory research studies. Additionally, Dr. Jimenez has lectured in many national and international scientific meetings and he is currently the co-chair of the International Society for Pheochromocytoma and Paraganglioma Research PRESSOR. His very focused and successful career has positioned him as an example to be followed by the new generations of endocrinologists.  Emblematic of this success, the Endocrine Society invited him, two years in succession, to give the honorary lecture titled “How I got here? A personal journey”.

Research Interests

Pheochromocytomas, Paragangliomas, Multiple Endocrine Neoplasias, Medullary Thyroid Cancer, Endocrine Sequelae of Cancer Therapies

Clinical Interests

Pheochromocytomas, Paragangliomas, Multiple Endocrine Neoplasias,Medullary Thyroid Cancer, Endocrine Sequelae of Cancer Therapies

For general clinic information and referrals, please visit the Department of Endocrine Neoplasia and Hormonal Disorders' contact information webpage at:

Contact Information

Education & Training

Degree-Granting Education

1995 Pontificia Universidad Javeriana, Santafe de Bogota, Colombia, MD, Medicine and Surgery

Postgraduate Training

7/2001-6/2004 Clinical Fellowship, Endocrinology, Diabetes and Metabolism, Baylor College of Medicine and The University of Texas MD Anderson Cancer Center, Houston, TX, Robert F. Gagel, MD
7/1999-6/2001 Clinical Residency, Internal Medicine, The University of Miami Jackson Memorial Hospital, Miami, FL, Jay Skyler, MD
6/1998-6/1999 Clinical Internship, Internal Medicine, The University of Miami Jackson Memorial Hospital, Miami, FL
7/1996-3/1998 Clinical Residency, Internal Medicine, The National Cancer Institute, Santafe de Bogota, Colombia

Board Certifications

2007 Endocrinology, Diabetes and Metabolism
1/2002 American Board of Internal Medicine

Experience/Service

Academic Appointments

Assistant Professor, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 11/2006-8/2012
Assistant Professor, The National Cancer Institute, Bogota, Colombia, 10/2004-6/2006

Selected Publications

Peer-Reviewed Original Research Articles

1. Thosani S, Ayala-Ramirez M, Palmer L, Hu MI, Rich T, Gagel RF, Cote G, Waguespack SG, Habra MA, Jimenez C. The Characterization of Pheochromocytoma and Its Impact on Overall Survival in Multiple Endocrine Neoplasia Type 2. J Clin Endocrinol Metab 98(11):E1813-9, 11/2013. e-Pub 9/12/2013. PMID: 24030942.
2. Jimenez C, Rohren E, Habra MA, Rich T, Jimenez P, Ayala-Ramirez M, Baudin E. Current and Future Treatments for Malignant Pheochromocytoma and Sympathetic Paraganglioma. Curr Oncol Rep 15(4):356-71, 8/2013. e-Pub 5/15/2013. PMID: 23674235.
3. Ayala-Ramirez M, Palmer JL, Hoffman MC, de la Cruz M, Moon BS, Waguespack SG, Habra MA, Jimenez C. Bone Metastases and Skeletal-Related Events in Patients with Malignant Pheochromocytoma and Sympathetic Paraganglioma. J Clin Endocrinol Metab. e-Pub 2/22/2013. PMID: 23436918.
4. Thosani N, Thosani SN, Kumar S, Nugent Z, Jimenez C, Singh H, Guha S. Reduced Risk of Colorectal Cancer with Use of Oral Bisphosphonates: A Systematic Review and Meta-analysis. J Clin Oncol 31(5):623-30, 2/10/2013. e-Pub 12/26/2012. PMID: 23269990.
5. Grubbs EG, Rich TA, Ng C, Bhosale PR, Jimenez C, Evans DB, Lee JE, Perrier ND. Long-term outcomes of surgical treatment for hereditary pheochromocytoma. J Am Coll Surg 216(2):280-9, 2/2013. PMID: 23317575.
6. Habra MA, Ejaz S, Feng L, Das P, Deniz F, Grubbs EG, Phan A, Waguespack SG, Ayala-Ramirez M, Jimenez C, Perrier ND, Lee JE, Vassilopoulou-Sellin R. A Retrospective Cohort Analysis of the Efficacy of Adjuvant Radiotherapy after Primary Surgical Resection in Patients with Adrenocortical Carcinoma. J Clin Endocrinol Metab 98(1):192-7, 1/2013. e-Pub 11/12/2012. PMCID: PMC3537094.
7. Dickson PV, Alex GC, Grubbs EG, Jimenez C, Lee JE, Perrier ND. Robotic-assisted retroperitoneoscopic adrenalectomy: making a good procedure even better. Am Surg 79(1):84-9, 1/2013. PMID: 23317617.
8. Carhill AA, Cabanillas ME, Jimenez C, Waguespack SG, Habra MA, Hu M, Ying A, Vassilopoulou-Sellin R, Gagel RF, Sherman SI, Busaidy NL. The Noninvestigational Use of Tyrosine Kinase Inhibitors in Thyroid Cancer: Establishing a Standard for Patient Safety and Monitoring. J Clin Endocrinol Metab 98(1):31-42, 1/2013. e-Pub 11/26/2012. PMCID: PMC3537108.
9. Ayala-Ramirez M, Chougnet CN, Habra MA, Palmer JL, Leboulleux S, Cabanillas ME, Caramella C, Anderson P, Al Ghuzlan A, Waguespack SG, Deandreis D, Baudin E, Jimenez C. Treatment with Sunitinib for Patients with Progressive Metastatic Pheochromocytomas and Sympathetic Paragangliomas. J Clin Endocrinol Metab 97(11):4040-50, 11/2012. e-Pub 9/10/2012. PMID: 22965939.
10. Chuang HH, Deniz F, Sircar K, Jimenez C, Rubin De Celis C, Wood CG, Habra MA. [18F]Fluorodeoxyglucose Positron Emission Tomography-Guided Therapy in Metastatic Adrenocortical Carcinoma: An Illustrative Case. J Clin Oncol 30(26):e246-9, 9/10/2012. e-Pub 5/29/2012. PMID: 22649135.
11. Morris GS, Landry CL, Grubbs EG, Jimenez C, Busaidy NL, Perrier ND. Older Patients with Primary Hyperparathyroidism have Greater than Age Predicted Functional Deficits. Endocr Pract. e-Pub 7/11/2012. PMID: 22784831.
12. Ayala-Ramirez M, Feng L, Habra MA, Rich T, Dickson PV, Perrier N, Phan A, Waguespack S, Patel S, Jimenez C. Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: Insights from the largest single-institutional experience. Cancer 118(11):2804-12, 6/1/2012. e-Pub 10/17/2011. PMID: 22006217.
13. Rianon N, Alex G, Callender G, Jimenez C, Hu M, Grubbs E, Moreno M, Wathoo C, Petak S, Perrier N. Preoperative Serum Osteocalcin may Predict Postoperative Elevated Parathyroid Hormone in Patients with Primary Hyperparathyroidism. World J Surg 36(6):1320-6, 6/2012. e-Pub 1/26/2012. PMID: 22278606.
14. Plouin PF, Fitzgerald P, Rich T, Ayala-Ramirez M, Perrier ND, Baudin E, Jimenez C. Metastatic Pheochromocytoma and Paraganglioma: Focus on Therapeutics. Horm Metab Res. e-Pub 2/2012. PMID: 22314389.
15. Peck BW, Rich TA, Jimenez C, Kupferman ME. A Novel SDHB Mutation Associated with Hereditary Head and Neck Paraganglioma. Laryngoscope 121(12):2572-5, 12/2011. PMID: 22109755.
16. Dickson PV, Alex GC, Grubbs EG, Ayala-Ramirez M, Jimenez C, Evans DB, Lee JE, Perrier ND. Posterior retroperitoneoscopic adrenalectomy is a safe and effective alternative to transabdominal laparoscopic adrenalectomy for pheochromocytoma. Surgery 150(3):452-8, 9/2011. PMID: 21878230.
17. Khan MI, Waguespack SG, Habra MA, Broaddus R, Jimenez C. Acute-Onset Ectopic Adrenocorticotropic Hormone Syndrome Secondary to Metastatic Endometrioid Carcinoma of the Ovaries As a Fatal Complication. J Clin Oncol 29(16):e462-4, 6/1/2011. e-Pub 3/21/2011. PMID: 21422435.
18. Varghese J, Ayala-Ramirez M, Rich T, Rohren E, Rao P, Jimenez C. Novel germline SDHD mutation: diagnosis and implications to the patient. Fam Cancer 10(2):365-71, 6/2011. e-Pub 2/12/2011. PMID: 21318381.
19. Dickson PV, Jimenez C, Chisholm GB, Kennamer DL, Ng C, Grubbs EG, Evans DB, Lee JE, Perrier ND. Posterior retroperitoneoscopic adrenalectomy: a contemporary american experience. J Am Coll Surg 212(4):659-65, 4/2011. PMID: 21463807.
20. Ejaz S, Vassilopoulou-Sellin R, Busaidy NL, Hu MI, Waguespack SG, Jimenez C, Ying AK, Cabanillas M, Abbara M, Habra MA. Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: The University of Texas MD Anderson Cancer Center Experience. Cancer. e-Pub 3/15/2011. PMID: 21412758.
21. Khan MI, Habra MA, McCutcheon IE, Nogueras-González GM, Devin JK, Busaidy NL, Levine NB, Lindstrom W, Kagan D, Jimenez C, Waguespack SG. Random postoperative day 3 cortisol as a predictor of hypothalamic-pituitary-adrenal axis integrity after transsphenoidal surgery. Endocr Pract. e-Pub 3/31/2011. PMID: 21454228.
22. Varghese J, Rich T, Jimenez C. Benign familial hypocalciuric hypercalcemia. Endocr Pract 17 Suppl 1:13-7, Mar-Apr, 3/2011. PMID: 21478088.
23. Ayala-Ramirez M, Feng L, Johnson MM, Ejaz S, Habra MA, Rich T, Busaidy N, Cote GJ, Perrier N, Phan A, Patel S, Waguespack S, Jimenez C. Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators. J Clin Endocrinol Metab 96(3):717-25, 3/2011. e-Pub 12/2010. PMID: 21190975.
24. Jasim S, Ying AK, Waguespack SG, Rich TA, Grubbs EG, Jimenez C, Hu MI, Cote G, Habra MA. Multiple Endocrine Neoplasia Type 2B with a RET Proto-Oncogene A883F Mutation Displays a More Indolent Form of Medullary Thyroid Carcinoma Compared With a RET M918T Mutation. Thyroid 21(2):189-92, 2/2011. e-Pub 12/2010. PMCID: PMC3025175.
25. Jimenez C, Ayala-Ramirez M, Liu J, Nunez R, Gagel RF. Inhibition of Growth Hormone Receptor Activation by Pegvisomant may Increase Bone Density in Acromegaly. Horm Metab Res 43(1):55-61, 1/2011. e-Pub 11/22/2010. PMID: 21104581.
26. Gómez K, Varghese J, Jiménez C. Medullary thyroid carcinoma: molecular signaling pathways and emerging therapies. J Thyroid Res 2011:815826, 2011. e-Pub 5/16/2011. PMCID: PMC3112527.
27. Ayala-Ramirez M, Habra MA, Busaidy N, Cote G, Rich T, Waguespack S, Jimenez C. A catecholamine crisis on Mount Kilimanjaro: a hypoxia effect? J Travel Med 17(6):424-6, Nov-Dec, 11/2010. PMID: 21050326.
28. Moskovic DJ, Smolarz JR, Stanley D, Jimenez C, Williams MD, Hanna EY, Kupferman ME. Malignant head and neck paragangliomas: Is there an optimal treatment strategy? Head Neck Oncol 2(1). e-Pub 9/23/2010. PMID: 20863367.
29. Waguespack SG, Rich T, Grubbs E, Ying AK, Perrier ND, Ayala-Ramirez M, Jimenez C. A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 95(5):2023-37, 5/2010. e-Pub 3/9/2010. PMID: 20215394.
30. Morris GS, Grubbs EG, Hearon CM, Gantela S, Lee JE, Evans DB, Holmes HM, Busaidy NL, Jimenez C, Perrier ND. Parathyroidectomy improves functional capacity in "asymptomatic" older patients with primary hyperparathyroidism: a randomized control trial. Ann Surg 251(5):832-7, 5/2010. PMID: 20395857.
31. Habra MA, Núñez R, Chuang H, Ayala-Ramirez M, Rich T, Kyle K, Jimenez C. Fatal hypoglycemia in malignant pheochromocytoma: direct glucose consumption as suggested by (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging. Endocrine 37(1):209-12, 2/2010. e-Pub 1/2010. PMID: 20963572.
32. Ayala-Ramirez M, Callender GG, Kupferman ME, Rich TA, Chuang HH, Trent J, Perrier ND, Goodarzi M, Jimenez C. Paraganglioma Syndrome Type 1 in a Patient with Carney-Stratakis Syndrome. Nat Rev Endocrinol 6(2):110-5, 2/2010. PMID: 20098451.
33. Lodish MB, Adams KT, Huynh TT, Prodanov T, Ling A, Chen C, Shusterman S, Jimenez C, Merino M, Hughes M, Cradic KW, Milosevic D, Singh RJ, Stratakis CA, Pacak K. Succinate dehydrogenase gene mutations are strongly associated with paraganglioma of the organ of Zuckerkandl. Endocr Relat Cancer 17(3):581-8, 2010. e-Pub 4/23/2010. PMID: 20418362.
34. Perrier ND, Balachandran D, Wefel JS, Jimenez C, Busaidy N, Morris GS, Dong W, Jackson E, Weaver S, Gantela S, Evans DB, Grubbs EG, Lee JE. Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with "asymptomatic" primary hyperparathyroidism. Surgery 146(6):1116-22, 12/2009. e-Pub 10/30/2009. PMID: 19879613.
35. Weaver S, Doherty DB, Jimenez C, Perrier ND.. Peer-Reviewed, Evidence-Based Analysis of Vitamin D and Primary Hyperparathyroidism. World J Surg 144(6):852-8, 11/2009. e-Pub 3/2009. PMID: 19308641.
36. Santarpia L, Habra MA, Jiménez C.. Malignant Pheochromocytomas and Paragangliomas: Molecular Signaling Pathways and Emerging Therapies. Horm Metab Res 41(9):680-6, 9/2009. e-Pub 4/2/2009. PMID: 19343618.
37. Shin SH, Holmes H, Bao R, Jimenez C, Kee SS, Potylchansky E, Lee JE, Evans DB, Perrier ND. Outpatient Minimally Invasive Parathyroidectomy is Safe for Elderly Patients. J Am Coll Surg 208(6):1071-6, 6/2009. e-Pub 4/17/2009. PMID: 19476894.
38. Stava CJ, Jimenez C, Hu MI, Vassilopoulou-Sellin R. Skeletal sequelae of cancer and cancer treatment. J Cancer Surviv 3(2). e-Pub 5/2/2009. PMID: 19412668.
39. Perrier ND, Edeiken B, Nunez R, Gayed I, Jimenez C, Busaidy N, Potylchansky E, Kee S, Vu T. A Novel Nomenclature to Classify Parathyroid Adenomas. World J Surg 33(3):412-6, 3/2009. PMID: 19148701.
40. Jaishuen A, Jimenez C, Sirisabya N, Li Y, Zheng H, Hu W, Urbauer DL, Kavanagh JJ. Poor Survival Outcome with Moderate and Severe Hypercalcemia in Gynecologic Malignancy Patients. Int J Gynecol Cancer 19(2):178-85, 2/2009. PMID: 19395991.
41. Jimenez C, Cabanillas ME, Santarpia L, Jonasch E, Kyle KL, Lano EA, Matin SF, Nunez RF, Perrier ND, Phan A, Rich TA, Shah B, Williams MD, Waguespack SG. Use of the Tyrosine Kinase Inhibitor Sunitinib in a Patient with von Hippel-Lindau Disease: Targeting Angiogenic Factors in Pheochromocytoma and other von Hippel-Lindau Disease-related Tumors. J Clin Endocrinol Metab 94(2):386-91, 2/2009. e-Pub 11/2008. PMID: 19017755.
42. Habra MA*, Jimenez C*(*Co-First Authors), Huang SC, Cote GJ, Murphy WA, Gagel RF, Hoff AO. Expression Analysis of Fibroblast Growth Factor-23, Matrix Extracellular Phosphoglycoprotein, Secreted Frizzled-Related Protein-4, and Fibroblast Growth Factor-7: Identification of Fibroblast growth factor-23 and Matrix Extracellular Phosphoglycoprotein as Major Factors Involved in Tumor-Induced Osteomalacia. Endocr Pract 14(9):1108-14, 12/2008. PMID: 19158050.
43. Grubbs EG, Rafeeq S, Jimenez C, Feng L, Lee JE, Evans DB, Perrier ND. Preoperative Vitamin D Replacement Therapy in Primary Hyperparathyroidism: Safe and Beneficial? Surgery 144(6):852-8; discussion 858-9, 12/2008. PMID: 19040987.
44. Jimenez C, Burman P, Abs R, Clemmons DR, Drake WM, Hutson KR, Messig M, Thorner MO, Trainer PJ, Gagel RF. Follow-up of Pituitary Tumor Volume in Patients with Acromegaly Treated with Pegvisomant in Clinical Trials. Eur J Endocrinol 159(5):517-23, 11/2008. e-Pub 8/15/2008. PMID: 18708436.
45. Perrier ND, Kennamer DL, Bao R, Jimenez C, Grubbs EG, Lee JE, Evans DB. Posterior Retroperitoneoscopic Adrenalectomy: Preferred Technique for Removal of Benign Tumors and Isolated Metastases. Ann Surg 248(4):666-74, 10/2008. PMID: 18936580.
46. Rich TA, Jonasch E, Matin S, Waguespack SG, Gombos DS, Santarpia L, Stolle C, Jimenez C. A novel von Hippel-Lindau point mutation presents as apparently sporadic pheochromocytoma. Cancer Invest 26(6):642-6, 7/2008. PMID: 18584357.
47. Jiménez C, Hu MI, Gagel RF. Management of Medullary Thyroid Carcinoma. Endocrinol Metab Clin North Am 37(2):481-96, 6/2008. PMID: 18502338.
48. Hu MI, Gagel RF, Jimenez C. Bone Loss in Patients With Breast or Prostate Cancer. Curr Osteoporos Rep 5(4):170-8, 12/2007. PMID: 18430392.
49. Stava CJ, Jimenez C, Vassilopoulou-Sellin R. Endocrine Sequelae of Cancer and Cancer Treatments. J Cancer Surviv 1(4). e-Pub 11/20/2007. PMID: 18648961.
50. Jimenez C,Cote GC,Arnold A,Gagel RF. Should Patients with Apparently Sporadic Pheochromocytomas or Paragangliomas be Screened for Hereditary Syndromes? The Journal of Clinical Endocrinology and Metabolism 91(8):2851-8, 8/2006.
51. Jimenez C, Yang Y, Kim HW, Al-Sagier F, Berry DA, El-Naggar AK, Patel S, Vassilopoulou-Sellin R, Gagel RF. Primary hyperparathyroidism and osteosarcoma: examination of a large cohort identifies three cases of fibroblastic osteosarcoma. J Bone Miner Res 20(9):1562-8, 9/2005. e-Pub 5/2005. PMID: 16059628.
52. Jimenez C, Gomez A, Veras L, Levis S, Roos B. Vitamin D Deficiency and Seasonal Variation in Adult South Florida Population. Journal of Clinical Endocrinology and Metabolism 90(3):1557-62, 3/2005.
53. Jimenez C, Moran SA, Sereti I, Wynne S, Yen PM, Falloon J, Davey RT, Sarlis NJ. Graves' disease after interleukin-2 therapy in a patient with human immunodeficiency virus infection. Thyroid 14(12):1097-102, 12/2004. PMID: 15650365.
54. Busaidy NL*, Jimenez C*(*Co-First Authors) Habra MA, Schultz PN, El-Naggar AK, Clayman GL, Asper JA, Diaz EM, Evans DB, Gagel RF, Garden A, Hoff AO, Lee JE, Morrison WH, Rosenthal DI, Sherman SI, Sturgis EM, Waguespack SG, Weber RS, Wirfel K, Vassilopoulou-Sellin R. Parathyroid Carcinoma: A 22-year Experience. Head and Neck 26(8):716-26, 8/2004. PMID: 15287039.
55. Jimenez C, Habra MA, Huang SC, El-Naggar A, Shapiro SE, Evans DB, Cote G, Gagel RF. Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation. J Clin Endocrinol Metab 89(8):4142-5, 8/2004. PMID: 15292360.
56. Jimenez C, Gagel RF. Genetic testing in endocrinology: lessons learned from experience with multiple endocrine neoplasia type 2 (MEN2). Growth Horm IGF Res 14 Suppl A:S150-7, 6/2004. PMID: 15135800.
57. Jimenez C, Dang GT, Schultz PN, El-Naggar A, Shapiro S, Barnes EA, Evans DB, Vassilopoulou-Sellin R, Gagel RF, Cote GJ, Hoff AO. A Novel Point Mutation of the RET Proto-Oncogene Involving the Second Intracellular Tyrosine Kinase Domain in a Family with Medullary Thyroid Carcinoma. J Clin Endocrinol Metab 7(7):3521-26, 2004. PMID: 15240641.

Invited Articles

1. Thosani S, Jimenez C. Opioid Induced Biochemical Alterations of the Neuroendocrine Axis. Expert Reviews in Endocrinology and Metabolism 6(5):705-713, 9/2011.
2. Waguespack SG, Rich TA, Perrier ND, Jimenez C, Cote GJ, Medscape. Management of medullary thyroid carcinoma and MEN2 syndromes in childhood. Nat Rev Endocrinol. e-Pub 8/2011. PMID: 21862994.
Other Articles
1. Pabón N, Garavito G, Jimenez C. Adrenocortical Carcinoma: Comments from the Adrenocortical Cancer Consensus. Revista Colombiana de Cancerología Vol. 10, No. 2, 1/2006.
2. Jimenez C, Cadena E, de Francisco J, Guevara G, Garavito G. Multiple Endocrine Neoplasia Type 2: A Model for Cancer Prevention. Revista Colombiana de Cancerología Vol. 9, No 2:23-27, 12/2005.
3. Builes C, De Francisco J, Garavito G, Jimenez C. Parathyroid Carcinoma, Preoperative preparation with Bisphosphonates prevents severe Hungry Bone Syndrome. Revista de la Asociación Colombiana de Osteoporosis y Metabolismo Mineral, 12/2005.
4. Jimenez C, Garavito G. Seminars in Oncologic Emergencies: Humoral Hypercalcemia of Malignancy. Revista Colombiana de Cancerología Vol. 9, No. 2:30-35, 12/2005.
5. Jimenez C. Bone Plasticity. Editorial Revista de la Asociación Colombiana de Osteoporosis y Metabolismo Mineral, 3/2005.

Abstracts

1. Dickson PV, Alex GC, Grubbs EG, Jimenez C, Lee JE, Perrier ND. Robotic Retroperitoneoscopic Adrenalectomy: Making a Good Procedure Even Better. ACS 97th Annual Clinical Congress, San Francisco, CA, 10/2011.
2. Alex G, Rianon N, Callender G, Moreno M, Jimenez C, Hu M, Grubbs E, Lee J, Perrier N. Preoperative Serum Osteocalcin May Predict Postoperative Elevated Parathyroid Hormone in Patients with Primary Hyperparathyroidism. International Association of Endocrine Surgeons (IAES), Yokohama, Japan, 8/2011.
3. Vu T, Warneke C, Grubbs L, Jimenez C, Perrier N. Vitamin D Supplementation Does Not Alter Size or Perfusion of Parathyroid Adenomas. International Association of Endocrine Surgery (IAES), Yokohama, Japan, 8/2011.
4. Alford EM, Murphy WA, Shah J, Jimenez C, Lee B, Hu M. An Unusual Case of Acquired and Rapid Osteosclerosis. ENDO 2011, Boston, MA, 6/2011.
5. Ayala-Ramirez M, Habra M, Busaidy N, Perrier N, Rich T, Waguespack S, Phan A, Patel S, Jimenez C. Clinical Benefits of Chemotherapy in Patients with Metastatic Pheochromocytomas and Sympathetic Paragangliomas: Review of the Largest Single-Institution Experience. ENDO 2011, Boston, MA, 6/2011.
6. Ayala-Ramirez M, Habra M, Rich T, Cote G, Busaidy N, Anderson P, Waguespack S, Phan A, Patel S, Jimenez C. Experience with the Tyrosine Kinase Inhibitor Sunitinib in Metastatic Pheochromocytomas and Paragangliomas. ENDO 2011, Boston, MA, 6/2011.
7. Varghese J, Ayala-Ramirez M, Vaporciyan A, Liao Z, Habra M, Jimenez C. Mediastinal Paragnaglioma: The Univeristy of Texas MD Anderson Cancer Center (MDACC) Experience. ENDO 2011, Boston, MA, 6/2011.
8. Pryma DA, Barrett JA, Coleman RE, Noto R, Jimenez C, Pampaloni MH, Serafini AN, Wahl RL, Kostakoglu L, LaFrance ND, Babich JW. Preliminary Data from an Ongoing Phase 2b Study of No Carrier Added 131 I-iobenguane (nca-MIBG) in Patients with Maligant Pheochromocytoma (Pheo). 2011 ASCO Annual Meeting, Chicago, IL, 6/2011.
9. Dickson PV, Jimenez C, Chisholm GB, Kennamer DL, Ng C, Grubbs EG, Evans DB, Lee JE, Perrier ND. Posterior Retroperitoneoscopic Adrenalectomy: A Contemporary American Experience (Shiply Award Winner). Southern Surgical Association, 12/2010.
10. Schmeler KM, Jhingran A, Iyer RB, Munsell M, Kim E, Jimenez C, Sun CC, Moore CL, Kitaka S, Eifel PJ, Klopp AH, Sood AK. Significant Decreases in Bone Mineral Density Associated with Pelvic Radiotherapy: A Prospective Logitudinal Study of Women with Gynecologic Malignancies. 13th Biennial Meeting of the International Gynecological Cancer Society (IGCS 2010), Prague, 10/2010.
11. Ying AK, Jasim S, Waguespack SG, Rich TA, Grubbs EG, Jimenez C, Cote G, Habra MA. Multiple Endocrine Neoplasia Type 2b with A ret Proto-Oncogene A883F Mutation Displays a More Indolent form of Medullary Thyroid Carcinoma Compared with RET M918T Mutation. MEN 2010 12th International Workshop on Multiple Endocrine Neoplasia, Gubbio, Italy, 9/2010.
12. Busaidy NL, Vu T, Grubbs E, Urbauer D, Kim E, Landry C, Jimenez C, Hu MI, Waguespack SG, Gomez H, Perrier ND. 4D Neck CT Versus SPECT/CT Using Tc99m Sestamibi in the Localization of Parathyroid Adenomas: Which Study and When?. The Endocrine Society's 92nd Annual Meeting and Expo, San Diego, CA, 6/2010.
13. Ayala-Ramirez M, Habra MA, Busaidy NL, Cote G, Rich TA, Waguespack SG, Jimenez C. A Catecholamine Crisis on Mount Kilimanjaro: A Hypoxia Effect?. The Endocrine Society's 92nd Annual Meeting and Expo, San Diego, CA, 6/2010.
14. Ejaz S, Waguespack SG, Sellin RV, Busaidy NL, Jimenez C, Ying AK, Hu MI, Cabanillas ME, Gagel RF, Habra MA. ACTH-Dependent Ectopic Cushing's Syndrome: The University of Texas M.D. Anderson Cancer Center Experience. The Endocrine Society's 92nd Annual Meeting and Expo, San Diego, CA, 6/2010.
15. Michaelis CL, Cote GJ, Santarpia L, Klein MJ, Gornet TG, Fritsche HA, Busaidy NL, Waguespack SG, Cabanillas ME, Hu MI, Jimenez C, Sherman SI. Detection of Circulating Tumor Cells (CTCs) in Patients with Thyroid Cancer. The Endocrine Society's 92nd Annual Meeting and Expo, San Diego, CA, 6/2010.
16. Barrera T, Rich TA, Perrier ND, McCutcheon IE, Jimenez C, Habra MA. Pheochromocytoma and Cushing's Disease: A Rare Combination with Unclear Etiology. The Endocrine Society's 92nd Annual Meeting and Expo, San Diego, CA, 6/2010.
17. Khan MI, McCutcheon IE, Nogueras-Gonzalez GM, Devin JK, Jimenez C, Habra MA, Levine NB, Waguespack SG. Post-Operative Day 3 Cortisol as a Predictor of HPA Axis Integrity after Transsphenoidal Surgery. The Endocrine Society's 92nd Annual Meeting and Expo, San Diego, CA, 6/2010.
18. Ayala-Ramirez M, Hernandez M, Habra MA, Busaidy NL, Cote G, Rich TA, Waguespack SG, Jimenez C. Survival Rates in Patients with Metastatic Pheochromocytomas and Paragangliomas. The Endocrine Society's 92nd Annual Meeting and Expo, San Diego, CA, 6/2010.
19. Westin JR, Thompson MA, Cataldo VD, Toth BB, Sanjorjo P, Bourgeois S, Jimenez C, Murphy W, Fanale M, Fayad L, Fowler N, Kwak L, McLaughlin P, Neelapu S, Pro B, Rodriguez A, Shah J, Hagemeister FB. Bone Loss in Lymphoma Patients Prior to Receiving Front-Line Therapy. Clinical Lymphoma, Myeloma & Leukemia 20(3 / June 2010):E32, 5/2010.
20. Westin JR, Thompson MA, Cataldo VD, Toth BB, Sanjorjo P, Bourgeois S, Jimenez C, Murphy WA, Kwak LW, Hagemeister FB. The Effect of Zoledronic Acid on the Prevention of Bone Loss in Lymphoma Patients Receiving First-line Therapy, 5/2010.
21. Lodish MB, Adams K, Huynh TT, Prodanov T, Ling A, Jimenez C, Stratakis CA, Pacak K. Succinate Dehydrogenase Mutations Are Strongly Associated With Paraganglioma of the Organ of Zuckerkandl in Pediatric and Adult Patients. 8th European Society of Pediatric Endocrinology, 9/2009.
22. Guthikonda A, Jimenez C. Thyroid Leukemia. AACE, Houston, 2009, 5/2009.
23. V.D. Cataldo, M.A. Thompson, B.B. Toth, P. Sanjorjo, S. Bourgeois, B.N. Bekele, C. Jimenez, W.A. Murphy, A.O. Huen, S.A. Byfield, F.B. Hagemeister. Zoledronic Acid for the Prevention of Bone Loss in Patients with Previously Untreated Lymphoma Undergoing Chemotherapy. ASCO, Orlando, 2009, 5/2009.
24. Callender GG, Moreno M, Jimenez C, Hu MI, Grubbs EG,. Osteocalcin: Preoperative Predictor of Bone Hunger after Parathyroidectomy. AACE, Houston 2009, 4/2009.
25. Cabanillas M, Nunez R, Williams M, Jimenez C. Suture Granulomas Represent a False Positive MIBG Result, 2nd International Symposium on Pheochromocytoma. Queens College Cambridge, UK, Sept 2008, 9/2008.
26. Jimenez C, Clemmons DR, Drake WM, Hutson KR, Thorner MO, Trainer PJ, Gagel RF. Long-Term Follow-up of Pituitary Tumor Volume in Patients with Acromegaly treated with Pegvisomant. ENDO 2005, 6/2005.
27. Jimenez C, Habra A, Busaidy N, Vasudevan A, Gagel RF, Sarlis, NJ. Capecitabine and Radiotherapy Induce Disease Stabilization in a Case of Poorly Differentiated Follicular Thyroid Carcinoma, 8/2004.
28. Busaidy NL, Hymes SR, Jimenez C, Habra MA, Sarlis NJ. Progression of Medullary Thyroid Carcinoma Manifested as Skin Metastasis with Inflammatory Features, 8/2004.
29. Busaidy N, Habra MA, Jimenez C, Gagel RF. Diabetes Mellitus: A Possible Paraneoplastic Syndrome?, 6/2004.
30. Jimenez C, Habra MA, Huang SC, El-Naggar A, Shapiro SE, Evans DB, Cote G, Gagel RF. Pheochromocytoma and Medullary Thyroid Carcinoma: A New Genotype-Phenotype Correlation of the RET Proto-Oncogene 891 Germline Mutation. J Clin Endocrinol Metab 89(8):4142-5, 6/2004. PMID: 15292360.
31. Jimenez C, Habra MA, Busaidy N, Vasudevan A, Gagel RF, Sarlis NJ. Portal Hypertension: Another Complication of Metastatic Medullary Thyroid Carcinoma, 6/2004.
32. Asper JA, Rosenthal DI, Garden AS, Clayman G, Jimenez C, Ang KK. Parathyroid Carcinoma: The Role of Postoperative Radiation Therapy (Oral Presentation), 5/2004.
33. Busaidy N, Jimenez C, Habra MA, Gagel RF. Secondary or Tertiary Hyperparathyroidism in Tumor Induced Osteomalacia, 5/2004.
34. Habra MA, Jimenez C, Busaidy N, Vassilopoulou-Sellin R. Hyperprolactinemia as Initial Manifestation of Cowden Syndrome, 4/2004.
35. Jimenez C, Burman P, Clemmons D, Drake W, Thorner M, Trainer P, Gagel RF. Long-term follow-up of Pituitary Tumor Volume in Patients with Acromegaly Treated with Pegvisomant, 2004.
36. Garavito G, Neira F, Mejia C, Restrepo L, Penagos P, Yeung, SCJ, Jimenez C. A Woman with Acromegaly, a Normal Pituitary, and a Parasellar Mass. Where is the Excessive Growth Hormone Secretion Coming From?, 12/2003.
37. Jimenez C, Kim HW, Al-Sagier F, El-Naggar A, Sellin R, Berry D, Gagel RF. Primary Hyperparathyroidism and Osteosarcoma: Examination of a Large Cohort Identifies Unique Characteristics (Oral Presentation), 9/2003.
38. Jimenez C, Maple S, Gagel R,. Bone Mineral Density in Patients with Acromegaly under Therapy with Pegvisomant. ENDO, Philadelphia 2002, 6/2003.
39. Jimenez C, Maple S, Al-Sghir F, Gagel R. Lack of Further Growth in the Size of 2 Pituitary Growth Hormone Producing Tumors After Initiation of Pegvisomant Therapy, 6/2003.
40. Jimenez C, Maple S, Schultz P, Gagel R. Treatment of Acromegaly with Pegvisomant, a Growth Hormone Receptor Antagonist, Does Not Reduce Bone Mass, 6/2003.
41. Busaidy N, Jimenez C, Habra M, Schultz P, El-Naggar A, Clayman G, Vassilopoulou-Sellin R. Parathyroid Carcinoma, The University of Texas M. D. Anderson Cancer Center Experience, 5/2003.
42. Jimenez C, Habra M, Busaidy N, Wirfel K, El-Naggar A, Vassilopoulou-Sellin R. 5. Parathyroid Carcinoma, MD Anderson Cancer Center Experience. Head and Neck Surgery Journal, 2003.
43. Roman F, Bentancourt M, Case C, Jimenez C,Wirfel K. Non-Islet Cell Tumor Hypoglycemia: Case presentation, Hormonal Evaluation and Options for Palliative Treatment, 5/2002.
44. Levis S, Gomez A, Jimenez C, Vera L, Hollis BW, Lai S, Roos B. Decreased Seasonal Variation in Vitamin D Levels in Medical Outpatients in Miami, Florida (Unites States). ENDO Denver, CO, 2003, 6/2001.
45. Gomez A, Veras L, Jimenez C, Hollis BW, Lai S, Roos B, Lewis S. Diminished Seasonal Vitamin D and PTH Changes in South Florida. Geriatrics, Chicago, IL,, 2001.
46. Levis S, Gomez A, Jimenez C, Veras L, Hollis BW, Lai S, Roos B. Sustained 25(OH) Vitamin D Levels Throughout the Year in the Elderly Population of South Florida. ECTS, Madrid, Spain May 2001, 2000.

Book Chapters

1. Jimenez C, Gagel RF,. Disorders affecting multiple endocrine systems. In: Harrison's Principles of Internal Medicine. 2, 18th. McGraw Hill, 2011.
2. Rich TA, Jimenez C, Evans DB. Hereditary Pheochromocytoma and Multiple Endocrine Neoplasia Type 2 (MEN2). In: Genetic Diagnosis of Endocrine Disorders, 2010.
3. Jimenez C, Gagel RF. Multiple Endocrine Neoplasia. In: Harrison's Hematology and Oncology. McGraw-Hill, 597-608, 2010.
4. Jimenez C, Gagel RF. Multiple Endocrine Neoplasias and Autoimmune Endocrinopathies. In: Harrison's Endocrinology, Second. McGraww-Hill, 367-378, 2010.
5. Jimenez C. Neuroendocrinology. In: Neurology, 2. Ed(s) Toro J, Yepes M, Palacios E. Manual Moderno: Mexico, 391-403, 2010.
6. Silberfein E, Jimenez C, Perrier N. Pheochromocytomas. In: Cameron, 2010.
7. Jimenez C, Gagel R. Disorders affecting multiple endocrine systems. In: Harrison's Principles of Internal Medicine, 17th. McGraw Hill, 2008.
8. Rich T, Jimenez C, Evans D. Genetic Evaluation of Pheochromocytomas. Genetic Diagnosis of Endocrine Disorders. In: Endocrine Neoplasms. Ed(s) First, 2008.
9. Jimenez C. Thyroid Cancer. In: Medicina Interna (Internal Medicine), First. Colombian Association of Internal Medicine, 2006.
10. Jimenez C, Garavito G, Ramos P. Neuroendocrine Tumors of the Gastrointestinal Tract. In: Gastroenterología, Second, 2005.

Grant & Contract Support

Title: Pilot Study of Clinical Validity of Veridex Cell Search Assay in Malignant Pheochromocytoma and Paraganglioma
Funding Source: CCTS Pilot Project RFA from University of Texas Health Science Center
Role: Principal Investigator
Duration: 2010 - present

Last updated: 7/25/2014